OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 68 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,236,856 | +36.8% | 3,743,875 | 0.0% | 6.17% | +34.2% |
| Q2 2023 | $33,807,191 | +160.2% | 3,743,875 | 0.0% | 4.60% | +147.3% |
| Q1 2023 | $12,991,246 | +41.6% | 3,743,875 | 0.0% | 1.86% | +72.9% |
| Q4 2022 | $9,172,494 | -11.2% | 3,743,875 | 0.0% | 1.08% | -15.4% |
| Q3 2022 | $10,333,000 | -32.2% | 3,743,875 | 0.0% | 1.27% | -54.6% |
| Q2 2022 | $15,238,000 | -4.5% | 3,743,875 | 0.0% | 2.80% | +35.2% |
| Q1 2022 | $15,949,000 | -54.5% | 3,743,875 | 0.0% | 2.07% | -42.8% |
| Q4 2021 | $35,043,000 | -66.0% | 3,743,875 | 0.0% | 3.61% | -51.4% |
| Q3 2021 | $103,181,000 | -1.5% | 3,743,875 | 0.0% | 7.44% | -15.5% |
| Q2 2021 | $104,754,000 | -15.7% | 3,743,875 | 0.0% | 8.80% | -27.4% |
| Q1 2021 | $124,222,000 | -31.0% | 3,743,875 | 0.0% | 12.12% | -21.4% |
| Q4 2020 | $180,006,000 | – | 3,743,875 | – | 15.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |